Developer docs
API playgroundTry for free, no card

Search company profiles

Virtonomy

Full company profile

uuid0000zml

Namestring
Virtonomy
Legal namestring
Virtonomy GmbH
Websiteurl
virtonomy.io
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Virtonomy is a Munich-based digital health company that provides a digital twin and medical simulation platform, branded as v-Patients, for cardiovascular medical device development. The platform enables medical device developers to perform virtual implantation, anatomical analysis, and performance simulations across thousands of virtual patients built from real clinical imaging data, replacing or reducing reliance on physical prototyping and animal testing. Its core technology combines AI-powered anatomical segmentation of CT, MRI, X-ray, and ultrasound DICOM data, proprietary DICOM-to-3D model conversion, statistical shape modeling for worst-case and edge-case anatomies, and a Smoothed Particle Hydrodynamics (SPH) meshless simulation method for fluid dynamics and structural mechanics, with NVIDIA GPU acceleration delivering up to 650% speedup over CPU baselines.

The platform is delivered through a tiered architecture: the core v-Patients web product for virtual cohort selection and 3D visualization, add-on modules for statistical shape modeling, AI coronary anatomical analysis, and simulation services spanning fluid dynamics, structural mechanics, device deployment, and performance modeling. Revenue is generated through quote-based enterprise subscriptions with multi-year contracts, cohort-specific virtual patient database access, and professional services for advanced simulation execution and regulatory consultation. The company serves cardiovascular medical device developers (heart valves, stents, catheters, cannulas, occluders, TAH, heart assist devices) and regulatory affairs teams, with a direct enterprise field sales motion anchored by free regulatory consultation workshops and device-specific demonstrations. Named enterprise customers include Boston Scientific, Medtronic, Biotronik, Getinge, Abiomed, RealHeart, Evaheart, Medira, NVT, and Intershunt. Regulatory positioning is a core commercial lever, with methods validated against ASME V&V 40 and ISO 5840, digital evidence accepted by FDA and EU regulatory bodies, and an ex-FDA advisor (Dr. Tina Morrison) supporting credibility. The company is incorporated as Virtonomy GmbH, founded around 2019, and has raised approximately $3.85M in disclosed funding led by Accenture Ventures in 2023.

Short descriptiontext

Virtonomy provides a digital twin platform (v-Patients) that enables cardiovascular medical device developers to perform virtual implantation, anatomical analysis, and regulatory-grade simulations across thousands of virtual patients, reducing development timelines and animal testing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device simulation, digital patient twins, in silico testing, cardiovascular device development, virtual clinical trials
Industry2 codes
PRIMARYEDAFAJAJ
Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYEDAFAJAC
Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
NAICS code1 code
  • Software Publishers513210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Medical Device Simulation Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1v-Patients SaaS Platform Subscription
TypeSubscription Recurring
Description

Subscription-based access to the v-Patients digital twin platform for virtual patient selection, 3D model access, and simulation capabilities. Pricing likely tiered by cohort size and simulation complexity.

virtonomy.io
2Simulation Services
TypeProfessional Services
Description

Professional services for advanced anatomical simulations including fluid dynamics, structural mechanics, device deployment, and performance modeling. Customers control simulations while Virtonomy handles technical difficulties.

virtonomy.io
3Regulatory Consultation Services
TypeProfessional Services
Description

Expert regulatory services including virtual testing plan drafting, FDA/EU compliance consultation, and validated virtual evidence report generation for regulatory submissions.

virtonomy.io
4Cohort-Specific Virtual Patient Database Access
TypeSubscription Recurring
Description

Access to curated virtual patient cohorts tailored to specific device types, pathologies, and demographic requirements for anatomical analysis and device fit validation.

virtonomy.io
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Custom enterprise licensing with quote-based pricing
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Pricing determined based on device type, cohort requirements, simulation complexity, and regulatory scope. No public price list available.

virtonomy.io
2Professional services for simulation and regulatory consultation
ModelOtherBilling cadenceMulti-year contract
Notes

Services offered alongside platform access; specific engagement scope and pricing negotiated per customer project.

virtonomy.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1v-Patients
Description

Virtonomy's virtual trial platform featuring digital patient twins for medical device development, enabling virtual implantation, simulation, and testing across patient populations.

virtonomy.io
Core offering1 text field

Virtonomy sells the v-Patients platform, an end-to-end digital twin and simulation solution that lets cardiovascular medical device developers perform virtual implantation, anatomical analysis, and validated simulations on thousands of virtual patients built from real clinical data. The offering combines a SaaS software platform with professional anatomical simulation services and FDA/EU regulatory consultation, supported by a proprietary database of 3D patient models and AI-powered automated device positioning.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Development timeline reduction from years to weeks
+5 more records
Product overview1 text field

Virtonomy offers v-Patients as a unified digital twin and simulation platform for medical device development, consisting of a core web-based platform complemented by specialized modules: a virtual patient cohort database containing thousands of 3D anatomical models, advanced statistical shape modeling for worst-case and edge-case analysis, anatomical simulation services covering fluid dynamics and structural mechanics, and regulatory consultation services for FDA/EU compliance. The platform enables medical device developers to perform virtual implantation and testing across diverse patient populations, replacing traditional physical testing with validated in silico evidence.

Product and service1 record
1v-Patients
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-01
Description

Strategic technology partnership leveraging NVIDIA AI infrastructure (L40S GPU on EC2 g6e instances) to enhance simulation performance. Achieved 650% speedup for high-resolution biomedical simulations. Collaboration enables GPU-accelerated coronary simulations, AI anatomical computation, and integration with NVIDIA Omniverse for digital twin environments.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Dassault Systèmes' Living Heart Project is the most direct competitor to Virtonomy, offering FDA-validated cardiovascular digital twin simulations for medical device development through the 3DEXPERIENCE platform. Both target heart valve, TAH, and cardiovascular implant developers with virtual patient testing and regulatory evidence generation.

TypeDirect peer
Description

FEops provides cardiovascular simulation software (HEARTguide) for structural heart device planning and TAVR/LAAC procedures using patient-specific digital twins. It is a direct competitor to Virtonomy in the cardiovascular in silico device testing space, particularly for heart valves and occluders.

TypeDirect peer
Description

InSilicoTrials operates a cloud platform aggregating validated in silico models for medical device and drug development, competing directly with Virtonomy's regulatory-focused simulation and virtual evidence services. Both target the same enterprise medtech customers with simulation-as-a-service offerings.

TypeDirect peer
Description

HeartFlow builds cardiovascular digital twins from CT imaging for FFR-CT analysis and coronary disease diagnosis, with overlap to Virtonomy's cardiovascular digital twin and AI-powered coronary analysis capabilities. Both leverage deep-learning image segmentation and validated computational models in cardiology.

TypeBroad incumbent
Description

Ansys is a broad simulation incumbent whose Ansys Discovery and Ansys LS-DYNA platforms are used in medical device design, fluid-structure interaction, and regulatory submissions. It competes with Virtonomy in computational mechanics for cardiovascular implants but from a general-purpose simulation position rather than a cardiovascular-specialist one.

TypeBroad incumbent
Description

Siemens Healthineers offers digital twin capabilities across cardiovascular imaging and device planning through its Healthineers portfolio. It overlaps with Virtonomy in cardiovascular imaging-based digital modeling but as part of a much broader medical imaging and diagnostics franchise.

TypeBroad incumbent
Description

Materialise provides 3D medical imaging software (Mimics) and patient-specific anatomical modeling for surgical planning and medical device development. It competes with Virtonomy's DICOM-to-3D model pipeline and anatomical analysis modules, particularly for cardiovascular and orthopedic applications.

TypeDirect peer
Description

Simpleware, now part of Synopsys, provides medical image segmentation and 3D model generation software used widely in medical device R&D. It directly overlaps with Virtonomy's DICOM processing pipeline and anatomical segmentation capabilities for cardiovascular and broader device development.

9Unlearn.AI
TypeEmerging player
Description

Unlearn.AI builds digital twin prognostic twins for clinical trial design and patient outcome prediction in pharma and biotech. It overlaps with Virtonomy's in silico trial thesis but focuses on drug trials and prognostic modeling rather than cardiovascular device testing.

TypeEmerging player
Description

Q Bio builds whole-body digital twin platforms from quantitative MRI for clinical insights and preventive health. It is an emerging player in the broader medical digital twin space, thematically comparable to Virtonomy's patient-twin approach but focused on diagnostic imaging rather than device development.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Virtonomy

Medical Device Simulation Softwarevirtonomy.io

Virtonomy provides a digital twin platform (v-Patients) that enables cardiovascular medical device developers to perform virtual implantation, anatomical analysis, and regulatory-grade simulations across thousands of virtual patients, reducing development timelines and animal testing.

What Virtonomy does

Virtonomy is a Munich-based digital health company that provides a digital twin and medical simulation platform, branded as v-Patients, for cardiovascular medical device development. The platform enables medical device developers to perform virtual implantation, anatomical analysis, and performance simulations across thousands of virtual patients built from real clinical imaging data, replacing or reducing reliance on physical prototyping and animal testing. Its core technology combines AI-powered anatomical segmentation of CT, MRI, X-ray, and ultrasound DICOM data, proprietary DICOM-to-3D model conversion, statistical shape modeling for worst-case and edge-case anatomies, and a Smoothed Particle Hydrodynamics (SPH) meshless simulation method for fluid dynamics and structural mechanics, with NVIDIA GPU acceleration delivering up to 650% speedup over CPU baselines.

The platform is delivered through a tiered architecture: the core v-Patients web product for virtual cohort selection and 3D visualization, add-on modules for statistical shape modeling, AI coronary anatomical analysis, and simulation services spanning fluid dynamics, structural mechanics, device deployment, and performance modeling. Revenue is generated through quote-based enterprise subscriptions with multi-year contracts, cohort-specific virtual patient database access, and professional services for advanced simulation execution and regulatory consultation. The company serves cardiovascular medical device developers (heart valves, stents, catheters, cannulas, occluders, TAH, heart assist devices) and regulatory affairs teams, with a direct enterprise field sales motion anchored by free regulatory consultation workshops and device-specific demonstrations. Named enterprise customers include Boston Scientific, Medtronic, Biotronik, Getinge, Abiomed, RealHeart, Evaheart, Medira, NVT, and Intershunt. Regulatory positioning is a core commercial lever, with methods validated against ASME V&V 40 and ISO 5840, digital evidence accepted by FDA and EU regulatory bodies, and an ex-FDA advisor (Dr. Tina Morrison) supporting credibility. The company is incorporated as Virtonomy GmbH, founded around 2019, and has raised approximately $3.85M in disclosed funding led by Accenture Ventures in 2023.

Virtonomy firmographics

Firmographics
Name
Virtonomy
Legal name
Virtonomy GmbH
Website
https://virtonomy.io
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Virtonomy provides a digital twin platform (v-Patients) that enables cardiovascular medical device developers to perform virtual implantation, anatomical analysis, and regulatory-grade simulations across thousands of virtual patients, reducing development timelines and animal testing.
Ownership category
akta.pro rank

Virtonomy industry classification

Industry
Product category
Medical Device Simulation Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYEDAFAJAJ
Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYEDAFAJAC
Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning

Keywords

  • Medical device simulation
  • Digital patient twins
  • In silico testing
  • Cardiovascular device development
  • Virtual clinical trials

Where Virtonomy is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Virtonomy business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. v-Patients SaaS Platform Subscription: Subscription-based access to the v-Patients digital twin platform for virtual patient selection, 3D model access, and simulation capabilities. Pricing likely tiered by cohort size and simulation complexity.
  2. Simulation Services: Professional services for advanced anatomical simulations including fluid dynamics, structural mechanics, device deployment, and performance modeling. Customers control simulations while Virtonomy handles technical difficulties.
  3. Regulatory Consultation Services: Expert regulatory services including virtual testing plan drafting, FDA/EU compliance consultation, and validated virtual evidence report generation for regulatory submissions.
  4. Cohort-Specific Virtual Patient Database Access: Access to curated virtual patient cohorts tailored to specific device types, pathologies, and demographic requirements for anatomical analysis and device fit validation.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractCustom enterprise licensing with quote-based pricing
OtherMulti-year contractProfessional services for simulation and regulatory consultation

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Virtonomy product offering

Product offering

Core offering

Virtonomy sells the v-Patients platform, an end-to-end digital twin and simulation solution that lets cardiovascular medical device developers perform virtual implantation, anatomical analysis, and validated simulations on thousands of virtual patients built from real clinical data. The offering combines a SaaS software platform with professional anatomical simulation services and FDA/EU regulatory consultation, supported by a proprietary database of 3D patient models and AI-powered automated device positioning.

Product overview

Virtonomy offers v-Patients as a unified digital twin and simulation platform for medical device development, consisting of a core web-based platform complemented by specialized modules: a virtual patient cohort database containing thousands of 3D anatomical models, advanced statistical shape modeling for worst-case and edge-case analysis, anatomical simulation services covering fluid dynamics and structural mechanics, and regulatory consultation services for FDA/EU compliance. The platform enables medical device developers to perform virtual implantation and testing across diverse patient populations, replacing traditional physical testing with validated in silico evidence.

Differentiator

Problem solved

Functional benefit

Brands

  • v-Patients: Virtonomy's virtual trial platform featuring digital patient twins for medical device development, enabling virtual implantation, simulation, and testing across patient populations.

Products and services

  • v-Patients

Quantifiable outcome

  • Development timeline reduction from years to weeks
  • +5 more outcomes

Companies that use Virtonomy

Customer profile

Named customers13 records

Segments3 records

Ideal customer profiles2 records

Virtonomy technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature8 records

Virtonomy partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NVIDIAcoreTechnology or Integration · 1 October 2025Strategic technology partnership leveraging NVIDIA AI infrastructure (L40S GPU on EC2 g6e instances) to enhance simulation performance. Achieved 650% speedup for high-resolution biomedical simulations. Collaboration enables GPU-accelerated coronary simulations, AI anatomical computation, and integration with NVIDIA Omniverse for digital twin environments.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Virtonomy competitors and assessment

Company assessment

Direct peers

  • Dassault Systèmes (Living Heart Project): Dassault Systèmes' Living Heart Project is the most direct competitor to Virtonomy, offering FDA-validated cardiovascular digital twin simulations for medical device development through the 3DEXPERIENCE platform. Both target heart valve, TAH, and cardiovascular implant developers with virtual patient testing and regulatory evidence generation.
  • FEops: FEops provides cardiovascular simulation software (HEARTguide) for structural heart device planning and TAVR/LAAC procedures using patient-specific digital twins. It is a direct competitor to Virtonomy in the cardiovascular in silico device testing space, particularly for heart valves and occluders.
  • InSilicoTrials: InSilicoTrials operates a cloud platform aggregating validated in silico models for medical device and drug development, competing directly with Virtonomy's regulatory-focused simulation and virtual evidence services. Both target the same enterprise medtech customers with simulation-as-a-service offerings.
  • HeartFlow: HeartFlow builds cardiovascular digital twins from CT imaging for FFR-CT analysis and coronary disease diagnosis, with overlap to Virtonomy's cardiovascular digital twin and AI-powered coronary analysis capabilities. Both leverage deep-learning image segmentation and validated computational models in cardiology.
  • Simpleware (Synopsys): Simpleware, now part of Synopsys, provides medical image segmentation and 3D model generation software used widely in medical device R&D. It directly overlaps with Virtonomy's DICOM processing pipeline and anatomical segmentation capabilities for cardiovascular and broader device development.

Broad incumbents

  • Ansys: Ansys is a broad simulation incumbent whose Ansys Discovery and Ansys LS-DYNA platforms are used in medical device design, fluid-structure interaction, and regulatory submissions. It competes with Virtonomy in computational mechanics for cardiovascular implants but from a general-purpose simulation position rather than a cardiovascular-specialist one.
  • Siemens Healthineers (Digital Twin / Heart Center): Siemens Healthineers offers digital twin capabilities across cardiovascular imaging and device planning through its Healthineers portfolio. It overlaps with Virtonomy in cardiovascular imaging-based digital modeling but as part of a much broader medical imaging and diagnostics franchise.
  • Materialise: Materialise provides 3D medical imaging software (Mimics) and patient-specific anatomical modeling for surgical planning and medical device development. It competes with Virtonomy's DICOM-to-3D model pipeline and anatomical analysis modules, particularly for cardiovascular and orthopedic applications.

Emerging players

  • Unlearn.AI: Unlearn.AI builds digital twin prognostic twins for clinical trial design and patient outcome prediction in pharma and biotech. It overlaps with Virtonomy's in silico trial thesis but focuses on drug trials and prognostic modeling rather than cardiovascular device testing.
  • Q Bio: Q Bio builds whole-body digital twin platforms from quantitative MRI for clinical insights and preventive health. It is an emerging player in the broader medical digital twin space, thematically comparable to Virtonomy's patient-twin approach but focused on diagnostic imaging rather than device development.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Virtonomy social profiles

Digital presence

Virtonomy compliance and trust

Trust signal

Compliance5 records

Virtonomy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Virtonomy leadership team

Management profile

Number of profiles

Profiles2 records

Virtonomy funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Virtonomy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virtonomy

What does Virtonomy do?

Virtonomy sells the v-Patients platform, an end-to-end digital twin and simulation solution that lets cardiovascular medical device developers perform virtual implantation, anatomical analysis, and validated simulations on thousands of virtual patients built from real clinical data. The offering combines a SaaS software platform with professional anatomical simulation services and FDA/EU regulatory consultation, supported by a proprietary database of 3D patient models and AI-powered automated device positioning.

Is Virtonomy a public or private company?

Virtonomy is a private company. It is classified as venture growth investor backed and is currently operating.

When was Virtonomy founded?

Virtonomy was founded in 2019. It employs 11 to 50 people.

Where is Virtonomy based?

Virtonomy is headquartered in Munich, Germany, in the Europe region.

How does Virtonomy make money?

Four revenue lines are on record. v-Patients SaaS Platform Subscription is the primary driver. The others are simulation Services, regulatory Consultation Services and cohort-Specific Virtual Patient Database Access.

Who are Virtonomy's main competitors?

Direct peers on record are Dassault Systèmes (Living Heart Project), FEops, InSilicoTrials, HeartFlow and Simpleware (Synopsys). Broad incumbents are Ansys, Siemens Healthineers (Digital Twin / Heart Center) and Materialise. Emerging players are Unlearn.AI and Q Bio.

Does Virtonomy have an API?

No public API is recorded for Virtonomy.

What industry is Virtonomy in?

Virtonomy's product category is Medical Device Simulation Software. Its primary akta.pro industry code is EDAFAJAJ, Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators), with a secondary code of EDAFAJAC, Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
deutsche-startups.deCODE sammelt 7 Millionen einCODE University of Applied Sciences, a Berlin-based private university founded in 2017, has raised over 7 million euros from institutional investors including GF BRYCK Ventures, IBB Capital, and Fadelia, along with business angels such as Stephan Schambach and Florian Heinemann. Since its founding, CODE students have established more than 230 companies. In separate DACH-region deals, virtual patient simulation company Virtonomy raised 5 million euros from Companisto and Bayern Kapital, while universal gift card startup Joy secured a total of 1.25 million euros including a 350,000-euro investment from venture capitalist Janna Ensthaler for a 15% equity stake.openPR.comDigital Twins Transforming Medical Diagnostics: Market Trends, Share Insights & Global Forecast | keyplayers are Qure.ai, BioSymetrics, Ansys, Virtonomy and among others.The digital twins in healthcare market is projected to grow at a CAGR of 18.1% from 2024 to 2031. Key players include Qure.ai, BioSymetrics, Ansys, and Virtonomy, with growth driven by AI, machine learning, and IoT. Data privacy and cybersecurity risks remain challenges.FinSMEsVirtonomy Receives Investment from Accenture VenturesVirtonomy, a Munich-based MedTech simulation provider, received an undisclosed investment from Accenture Ventures. The company will use the funds to extend its capabilities to medical technology firms. Founded in late 2019, Virtonomy develops cloud-based digital twin solutions for clinical study design and execution.Business Wire BlogAccenture Invests in Virtonomy to Help Medical Technology Companies Use Digital Twin Technology to Accelerate Time to Market for Medical DevicesAccenture made a strategic investment in Virtonomy, a provider of data-driven simulations using digital twin technology to accelerate medical device development. The investment aims to help Virtonomy expand its capabilities for medical technology companies, reducing costs and regulatory complexity. The deal is part of Accenture Ventures' Project Spotlight program.DvH VenturesVirtonomy secures €3.5m funding to scale digital patient twins in medical device developmentMunich-based startup Virtonomy has secured €3.5 million in pre-Series A funding to expand its digital patient twin platform for medical device development. The round was co-led by Dieter von Holtzbrinck Ventures and joined by investors including Accenture, Bayern Kapital, and Industrial Innovators. The capital will be used to scale the technology globally, aiming to streamline regulatory approvals and reduce reliance on traditional clinical trials.